Our preliminary exploration of the mechanisms that LOC401317 utilizes as a tumor suppressor shows that LOC401317 may cause cell cycle arrest by increasing p21 expression and decreasing cyclin D1 and cyclin E1 expression. Here, CCNE1 is linked to neoplasm.